China Medical Technologies, Inc. (the "Company") is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology, and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders.
BEIJING, June 19, 2009 /PRNewswire-Asia-FirstCall via COMTEX/ -- China Medical Technologies,
Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products today announced selected unaudited preliminary financial results for
the fourth fiscal quarter (''4Q FY2008'') and the full year of the fiscal year
ended March 31, 2009 (''FY2008''). The Company's 2008 fiscal year ends on
March 31, 2009.
...
BEIJING, April 27 /PRNewswire-Asia-FirstCall/ -- China Medical
Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based
medical device company that develops, manufactures and markets advanced
in-vitro diagnostic products, today announced that the Company has received
approval for its Bladder Cancer FISH Probe (the "Probe") from the State Food
and Drug Administration (the "SFDA") in the People's Republic of China.
The Probe is an advanced molecular diagnostic test ...
BEIJING, March 25 /PRNewswire-Asia-FirstCall/ -- China Medical
Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based
medical device company that develops, manufactures and markets advanced
in-vitro diagnostic products, today announced that the Company received
quality testing certificate (the ''Certificate'') for its SPR-based Analysis
System (the ''SPR System'') from one of the State Food and Drug Administration
(the ''SFDA'') Quality Supervision and Testing Centr...
BEIJING, March 6 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro diagnostic
products, today announced that each of Mr. Xiaodong Wu, the Company's Chairman
and Chief Executive Officer, Mr. Sam Tsang, the Company's Chief Financial
Officer and Dr. Zhong Chen, the Company's Chief Technology Officer, purchased
the Company's American Depositar...
Stock Quote
July 2009
?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Sign up to receive e-mail alerts whenever China Medical Technologies, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.